Adalimumab in psoriatic arthritis: 24-week results of a phase III study

被引：0
|
作者：
Mease, P
Gladman, D
Ritchlin, C
Weinberg, M
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Rochester, Rochester, NY USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P2 / P2
页数：1
相关论文
共 50 条
  • [21] Tildrakizumab Efficacy for Psoriatic Arthritis: 24-week Analysis of Swollen and Tender Joint Counts and Pain
    Orbai, Ana-Maria
    Ballerini, Rocco
    Chou, Richard C.
    Rozzo, Stephen
    Mendelsohn, Alan
    Espinoza, Luis R.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [22] SECUKINUMAB IMPROVES SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: A 24-WEEK, DOUBLE-BLIND, TRIAL
    McInnes, I.
    Sieper, J.
    Braun, J.
    Emery, P.
    van der Heijde, D.
    Isaacs, J.
    Dahmen, G.
    Wollenhaupt, J.
    Schulze-Koops, H.
    Gsteiger, S.
    Bertolino, A. P.
    Hueber, W.
    Tak, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 619 - 619
  • [23] EFFECT OF CERTOLIZUMAB PEGOL ON THE MULTIPLE FACETS OF PSORIATIC ARTHRITIS AS REPORTED BY PATIENTS: 24-WEEK PATIENT-REPORTED OUTCOME RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    Gladman, D.
    Fleischmann, R.
    Coteur, G.
    Woltering, F.
    Mease, P.
    RHEUMATOLOGY, 2013, 52 : 163 - 163
  • [24] Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain
    Espinoza, Luis R.
    Ballerini, Rocco
    Chou, Richard
    Rozzo, Stephen J.
    Mendelsohn, Alan M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB166 - AB166
  • [25] Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study
    Jonathan Kay
    Janusz Jaworski
    Rafal Wojciechowski
    Piotr Wiland
    Anna Dudek
    Marek Krogulec
    Slawomir Jeka
    Agnieszka Zielinska
    Jakub Trefler
    Katarzyna Bartnicka-Maslowska
    Magdalena Krajewska-Wlodarczyk
    Piotr A. Klimiuk
    Sang Joon Lee
    Yun Ju Bae
    Go Eun Yang
    Jae Kyoung Yoo
    Daniel E. Furst
    Edward Keystone
    Arthritis Research & Therapy, 23
  • [26] Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study
    Kay, Jonathan
    Jaworski, Janusz
    Wojciechowski, Rafal
    Wiland, Piotr
    Dudek, Anna
    Krogulec, Marek
    Jeka, Slawomir
    Zielinska, Agnieszka
    Trefler, Jakub
    Bartnicka-Maslowska, Katarzyna
    Krajewska-Wlodarczyk, Magdalena
    Klimiuk, Piotr A.
    Lee, Sang Joon
    Bae, Yun Ju
    Yang, Go Eun
    Yoo, Jae Kyoung
    Furst, Daniel E.
    Keystone, Edward
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [27] Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Choy, EHS
    Steinfeld, SD
    Perdok, R
    Sasso, EH
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S215 - S215
  • [28] EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE: 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    Mease, P.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Kielar, D.
    Woltering, F.
    Stach, C.
    Hoepken, B.
    Arledge, T.
    van der Heijde, Desiree
    RHEUMATOLOGY, 2013, 52 : 162 - 163
  • [29] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CSDMARDS: SUMMARY RESULTS FROM THE 24-WEEK PHASE III RA-BUILD STUDY
    Emery, Paul
    Krogulec, Marek
    Blanco Alonso, Ricardo
    Rossini, Maurizio
    Raeman, Frank
    Walker, David
    Ghizdavescu, Andrei Petru
    Irto, Ildiko
    Luz Rentero, Maria
    Casillas, Marta
    de la Torre, Inmaculada
    Dougados, Maxime
    RHEUMATOLOGY, 2016, 55 : 60 - 60
  • [30] The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial
    Bingham, Clifton O., III
    Weinblatt, Michael
    Han, Chenglong
    Gathany, Timothy A.
    Kim, Lilianne
    Lo, Kim Hung
    Baker, Dan
    Mendelsohn, Alan
    Westhovens, Rene
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1067 - 1076
12345